Inhibrx Biosciences, Inc.
INBX
$82.96
$0.710.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.94% | -13.83% | 41.89% | -22.28% | -13.46% |
| Total Receivables | -13.44% | 351.87% | -49.05% | -62.73% | -18.75% |
| Inventory | -9.19% | 31.29% | -5.46% | -34.60% | -38.05% |
| Prepaid Expenses | 45.06% | -8.35% | -36.19% | -17.79% | -25.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.85% | -28.20% | 74.62% | -34.89% | -11.62% |
| Total Current Assets | -16.78% | -13.17% | 39.27% | -22.68% | -14.30% |
|
|
|||||
| Total Current Assets | -16.78% | -13.17% | 39.27% | -22.68% | -14.30% |
| Net Property, Plant & Equipment | -9.12% | -8.88% | -8.04% | 61.09% | -12.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.73% | 0.09% | -0.41% | 1.77% | -0.49% |
| Total Assets | -16.33% | -12.58% | 34.23% | -18.78% | -13.88% |
|
|
|||||
| Total Accounts Payable | -24.20% | -4.79% | 18.06% | 9.09% | -22.28% |
| Total Accrued Expenses | 5.07% | -16.83% | -0.65% | -15.26% | 48.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.60% | 9.93% | 23.70% | -13.08% | -15.48% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.59% | -10.77% | 7.14% | -7.63% | 12.91% |
|
|
|||||
| Total Current Liabilities | -7.59% | -10.77% | 7.14% | -7.63% | 12.91% |
| Long-Term Debt | 0.64% | 0.63% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.23% | -9.54% | -8.51% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.03% | -3.13% | 214.09% | 7.00% | 12.91% |
|
|
|||||
| Common Stock & APIC | 1.43% | 1.14% | 1.74% | 1.26% | 1.27% |
| Retained Earnings | -19.80% | -19.17% | -40.81% | -82.15% | -304.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -46.28% | -27.41% | -29.30% | -25.15% | -18.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.28% | -27.41% | -29.30% | -25.15% | -18.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -46.28% | -27.41% | -29.30% | -25.15% | -18.64% |
|
|
|||||